Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood Advances|March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donorsAsad Bashey, Xu Zhang, Lawrence E Morris, et al.
Transplantation and Cellular Therapy|June 15, 2024
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based TransplantationScott R Solomon, Lizamarie Bachier-Rodriguez, Asad Bashey, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2019
Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to AllograftsDiego Adrianzen Herrera, Noah Kornblum, Olga Derman, et al.
Experimental Hematology & Oncology|December 10, 2021
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohortEmma Rabinovich, Kith Pradhan, R Alejandro Sica, et al.
Blood Advances|June 28, 2023
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplantScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Transplantation and Cellular Therapy|April 1, 2024
Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical TransplantScott R Solomon, Michael T Aubrey, Lizamarie Bachier-Rodriguez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2019
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary CenterDiego Adrianzen Herrera, Noah Kornblum, Ana Acuna-Villaorduna, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Journal of Hematology & Oncology|January 5, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitisAhmed Abbasi, Stephen Peeke, Nishi Shah, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Pageof 2